tiprankstipranks
Trending News
More News >
Innovent Biologics (HK:1801)
:1801
Hong Kong Market

Innovent Biologics (1801) Cash flow

Compare
21 Followers

Innovent Biologics Cash Flow

HK:1801's free cash flow for Q2 2025 was ¥0.00. For the 2025 fiscal year, HK:1801's free cash flow was decreased by ¥817.26M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 1.29B¥ 147.81M¥ -1.92B¥ -2.02B¥ -307.69M
Investing Cash Flow
¥ -1.17B¥ -998.66M¥ -1.44B¥ -2.70B¥ -5.18B
Financing Cash Flow
¥ -606.63M¥ 2.59B¥ 2.89B¥ 5.00B¥ 4.91B
End Cash Position
¥ 2.27B¥ 2.75B¥ 1.02B¥ 1.36B¥ 1.28B
Free Cash Flow
¥ -418.39M¥ -1.24B¥ -3.30B¥ -3.87B¥ -1.08B
Currency in CNY

Innovent Biologics Cash Flow